文献速递脑血管病外科神经重症

揭示微小颅内动脉瘤:一项回顾性风险评估

Shedding light on tiny intracranial aneurysms: a retrospective risk assessment.
PubMed 文献 · J Neurosurg · 2025-05-23

本研究回顾性分析2010至2020年收治的蛛网膜下腔出血患者(n=427)及2012至2022年动脉瘤委员会讨论的未破裂颅内动脉瘤患者(n=743),筛选出最大径3 mm的单发微小动脉瘤。结果显示不规则形态(OR 4.53,95%CI 1.84-11.16;p<0.001)和高尺寸比/纵横比(>3/1.6;OR 14.73,95%CI 3.55-61.17;p<0.001)与破裂显著相关。

要点

  • 微小动脉瘤中不规则形态与破裂显著相关(OR 4.53)。
  • 高尺寸比/纵横比(>3/1.6)与破裂显著相关(OR 14.73)。
  • 回顾性应用UIATS*,仅20.3%的蛛网膜下腔出血微小动脉瘤会被推荐干预。

核心结论

  • 在本研究队列中可识别出若干破裂的微小动脉瘤,但仅少数会被推荐治疗。
  • 尤其不规则形态和异常构型的微小动脉瘤应审慎评估破裂风险。
  • 现有评分系统提供有价值的指导,但应与个体化、多学科治疗方法结合使用。

研究设计与样本

  • 回顾性分析,利用2010至2020年汉堡-埃彭多夫大学医学中心收治的动脉瘤性蛛网膜下腔出血患者(n=427)数据。
  • 同时纳入2012至2022年该中心动脉瘤委员会讨论的未破裂颅内动脉瘤患者(n=743)。
  • 筛选最大直径3 mm的单发微小动脉瘤进行进一步分析。
  • 比较蛛网膜下腔出血组与未破裂颅内动脉瘤组的人口学、动脉瘤特征及危险因素。
  • 在未破裂颅内动脉瘤患者中收集改良UIATS*和PHASES评分,并回顾性应用于蛛网膜下腔出血患者入院时。

主要发现

  • 在蛛网膜下腔出血队列中识别出79个微小动脉瘤,在未破裂颅内动脉瘤队列中识别出109个微小动脉瘤。
  • 比较两组微小动脉瘤,不规则形态与破裂显著相关(OR 4.53,95%CI 1.84-11.16;p<0.001)。
  • 高尺寸比/纵横比(>3/1.6)与破裂显著相关(OR 14.73,95%CI 3.55-61.17;p<0.001)。
  • 回顾性应用UIATS*于微小动脉瘤,推荐干预的比例在蛛网膜下腔出血组为20.3%,在未破裂颅内动脉瘤组为0.9%(p<0.001)。
  • 对于非微小动脉瘤,推荐干预的比例在蛛网膜下腔出血组为33.9%,在未破裂颅内动脉瘤组为15.6%(p<0.001)。

关键数值与推荐

  • 微小动脉瘤定义为最大直径3 mm。
  • 不规则形态与破裂的OR为4.53(95%CI 1.84-11.16;p<0.001)。
  • 尺寸比/纵横比>3/1.6与破裂的OR为14.73(95%CI 3.55-61.17;p<0.001)。
  • UIATS*推荐干预比例:蛛网膜下腔出血组20.3% vs 未破裂颅内动脉瘤组0.9%(p<0.001)。
  • 非微小动脉瘤UIATS*推荐干预比例:蛛网膜下腔出血组33.9% vs 未破裂颅内动脉瘤组15.6%(p<0.001)。

临床怎么用

  • 作者认为,尤其不规则形态和异常构型的微小动脉瘤应审慎评估破裂风险。
  • 作者认为,当前评分系统提供有价值的指导,但应与个体化、多学科治疗方法结合使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Tiny intracranial aneurysms (tiAs) pose challenges in detection and management. Recent advances in neuroimaging have improved the detection rates of these diminutive lesions, yet the decision-making process regarding their treatment remains controversial. While larger aneurysm size is a relevant risk factor for a possible rupture in common risk scores, the rupture of tiAs leading to subarachnoid hemorrhage (SAH) is also reported frequently. However, a heterogeneity in practice exists, and clear guidelines for the treatment of incidental tiAs are lacking. The aim of this study was to investigate clinical decision-making for aneurysm repair by investigating the risk factors for rupture in tiny aneurysms. METHODS: This retrospective analysis utilized data from patients admitted to the University Medical Center Hamburg-Eppendorf for aneurysmal SAH (n = 427) between 2010 and 2020 and patients with unruptured intracranial aneurysm (UIAs) discussed by the medical center's aneurysm board (n = 743) between 2012 and 2022. Patients with single tiAs, defined as a maximum diameter of 3 mm, were selected for further analysis. Patient demographics, aneurysm characteristics, and risk factors were compared between the SAH and UIA groups. A modified UIA treatment score (UIATS*) and the PHASES (population, hypertension, age, size of aneurysm, earlier SAH from another aneurysm, site of aneurysm) score were collected in UIA patients and applied retrospectively in SAH patients for the time of admission. RESULTS: The authors identified 79 tiAs in the SAH cohort and 109 tiAs in the UIA cohort. Irregular morphology (OR 4.53, 95% CI 1.84-11.16; p < 0.001) and a high size ratio/aspect ratio (> 3/1.6; OR 14.73, 95% CI 3.55-61.17; p < 0.001) were significantly associated with rupture when comparing tiAs of the SAH and UIA groups. When applying the UIATS* to tiny aneurysms retrospectively, intervention would have been recommended in 20.3% of SAH cases compared with 0.9% of UIA cases (p < 0.001). Comparatively, for nontiny aneurysms, intervention would have been recommended in 33.9% of SAH cases compared with 15.6% of UIA cases (p < 0.001). CONCLUSIONS: In the present collective, several ruptured tiAs could be identified. Nevertheless, only a few would have been recommended for treatment. Especially tiAs with irregular morphology and abnormal configurations should be critically evaluated for rupture risk. Current scoring systems provide valuable guidance but should be used in conjunction with individualized, multidisciplinary treatment approaches.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sauvigny J, Muzaiek S, Czorlich P, et al. Shedding light on tiny intracranial aneurysms: a retrospective risk assessment. J Neurosurg. 2025. PMID: 40408877. doi:10.3171/2025.2.JNS242537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。